Motherwort Pellets Brand Ranking

Kuihua Pharmaceutical Group Co., Ltd. is based on the mission of "guaranteeing the safety of Chinese children's medication, protecting the healthy growth of Chinese children. Being a good medicine for the people and bringing a healthy and beautiful life to hundreds of millions of families". It has a brand OTC product as the core and covers R&D. , well-known pharmaceutical companies in the entire industrial chain. The group was formerly the former state-owned Wuchang Pharmaceutical Factory in Heilongjiang Province. In 1998, it was reorganized into a private enterprise, Heilongjiang Kuihua Pharmaceutical Co., Ltd., and then continued to grow and grew. In 2005, Kuihua Pharmaceutical Group Co., Ltd. was established. The group currently has 32 subsidiaries including 13 pharmaceutical production enterprises, 6 sales companies, 4 pharmaceutical research institutes, 2 medicinal materials planting bases, and 1 pharmaceutical packaging company. It is headquartered in Harbin City. Listed in Shenzhen at the end of 2014, with stock code: 002737. The company is currently the executive vice president unit of the All-China Federation of Industry and Commerce Pharmaceutical Industry Chamber of Commerce, the vice president unit of the China Pharmaceutical Enterprise Management Association, the vice president unit of the China Pharmaceutical Business Association, the member unit of the China Traditional Chinese Medicine Association, and the vice president of the Chronic Disease Professional Committee of the China Traditional Chinese Medicine Association Unit, senior vice president unit of China Over-the-counter Drug Association, etc. Kuihua Pharmaceutical Group is dominated by traditional Chinese medicine, with "chemical drugs, biological drugs" and "healthy and health products" as its two wings, and is in the six major fields of "pediatrics, gynecology, digestive system, respiratory colds, rheumatism and bone diseases, and cardiovascular and cerebrovascular diseases". It has formed a comprehensive layout of product pipelines and has a rich product line, with a total of 21 dosage forms, 257 products in production, and 1,126 drug approval numbers. Among them, nearly 100 children's medicine approval numbers have been held and more than 60 sold drug products. Xiao Kuihua Children's Medicine has unshakable advantages in the same category in the OTC field in terms of "sales scale, product quantity, and scale single products". . The company is an OTC large-scale enterprise with "dual brand umbrellas". "Sunflower" and "Little Sunflower" have built the consumer trust foundation for the company's adult medicine and children's medicine. After more than 20 years of creation, the company has adopted the combination marketing model of "brand model, general medicine model, prescription model, big health model, new retail model" and other combination marketing models to build a unique combination marketing and full model in the industry. The integration model has attracted attention and imitation in the industry.

SUNFLOWER

Sunflower Pharmaceutical Group Co., Ltd.

Kuihua Pharmaceutical Group Co., Ltd. is based on the mission of "guaranteeing the safety of Chinese children's medication, protecting the healthy growth of Chinese children. Being a good medicine for the people and bringing a healthy and beautiful life to hundreds of millions of families". It has a brand OTC product as the core and covers R&D. , well-known pharmaceutical companies in the entire industrial chain. The group was formerly the former state-owned Wuchang Pharmaceutical Factory in Heilongjiang Province. In 1998, it was reorganized into a private enterprise, Heilongjiang Kuihua Pharmaceutical Co., Ltd., and then continued to grow and grew. In 2005, Kuihua Pharmaceutical Group Co., Ltd. was established. The group currently has 32 subsidiaries including 13 pharmaceutical production enterprises, 6 sales companies, 4 pharmaceutical research institutes, 2 medicinal materials planting bases, and 1 pharmaceutical packaging company. It is headquartered in Harbin City. Listed in Shenzhen at the end of 2014, with stock code: 002737. The company is currently the executive vice president unit of the All-China Federation of Industry and Commerce Pharmaceutical Industry Chamber of Commerce, the vice president unit of the China Pharmaceutical Enterprise Management Association, the vice president unit of the China Pharmaceutical Business Association, the member unit of the China Traditional Chinese Medicine Association, and the vice president of the Chronic Disease Professional Committee of the China Traditional Chinese Medicine Association Unit, senior vice president unit of China Over-the-counter Drug Association, etc. Kuihua Pharmaceutical Group is dominated by traditional Chinese medicine, with "chemical drugs, biological drugs" and "healthy and health products" as its two wings, and is in the six major fields of "pediatrics, gynecology, digestive system, respiratory colds, rheumatism and bone diseases, and cardiovascular and cerebrovascular diseases". It has formed a comprehensive layout of product pipelines and has a rich product line, with a total of 21 dosage forms, 257 products in production, and 1,126 drug approval numbers. Among them, nearly 100 children's medicine approval numbers have been held and more than 60 sold drug products. Xiao Kuihua Children's Medicine has unshakable advantages in the same category in the OTC field in terms of "sales scale, product quantity, and scale single products". . The company is an OTC large-scale enterprise with "dual brand umbrellas". "Sunflower" and "Little Sunflower" have built the consumer trust foundation for the company's adult medicine and children's medicine. After more than 20 years of creation, the company has adopted the combination marketing model of "brand model, general medicine model, prescription model, big health model, new retail model" and other combination marketing models to build a unique combination marketing and full model in the industry. The integration model has attracted attention and imitation in the industry.

Guilin Sanjin Pharmaceutical Co., Ltd. is the core enterprise of Sanjin Group. It mainly engages in the research and development and production of traditional Chinese medicine and natural medicines. It is one of the earliest manufacturers in China to produce modern Chinese medicine preparations. Since 1985, Guilin Sanjin has insisted on reform and innovation, relying on scientific and technological progress and scientific management, and has transformed from an unknown small traditional Chinese medicine workshop into a nationally renowned modern traditional Chinese medicine enterprise. As a well-known high-tech enterprise inside and outside the district, Sanjin has established innovative platforms such as nationally recognized enterprise technology centers, postdoctoral research workstations and Guangxi Institute of Traditional Chinese Medicine Industrialization Engineering. Over the years, we have been committed to promoting and implementing the modernization plan of the traditional Chinese medicine industry and actively cultivating and improving the independent innovation capabilities of enterprises. The company's new special Chinese medicines are all developed by the enterprise technology center. At present, Sanjin has more than 200 registered varieties and 13 pharmaceutical dosage forms, and has 42 special varieties independently developed by Guilin Watermelon Cream, Watermelon Cream Throat Soft Tablets, Sanjin Tablets, Naomaitai Capsules, etc. After years of hard work, Sanjin has formed strong professional and market advantages in throat, oral medication and urinary system medication. Its representative products, Sanjin Watermelon Cream Series and Sanjin Tablets, have been at the forefront of similar Chinese patent medicines in the country for many years. In July 2009, Guilin Sanjin successfully entered the capital market with a new look of high growth and high efficiency, and ushered in a new stage of rapid development of the enterprise. In recent years, in order to actively respond to the call of Guilin Municipal Party Committee and Municipal Government to "develop westward and create a new Guilin", and to resolve the contradiction between the dispersed production bases and warehousing facilities of enterprises and the rapid development of enterprises, Sanjin has launched the "Sanjin". The construction of the modern traditional Chinese medicine industrialization technology transformation project. At present, the first phase of the project has been officially put into production and the overall relocation of the main production lines has been achieved. Facing the future, Sanjin will uphold the corporate mission of "innovation to promote pharmaceutical progress" and the corporate spirit of "dare to be the first", implement the "one body and two wings" development strategy with traditional Chinese medicine as the main body and committed to developing biopharmaceuticals and the big health industry, Quality and reputation are the first life of the enterprise, breakthroughs and innovation, continuously enhances the competitive strength of Sanjin, and is enterprising, with the goal of developing to serve the country and repay investors, and with the goal of building China's advanced pharmaceutical manufacturing group, we will promote the modernization and internationalization of the traditional Chinese medicine industry!

Guilin Sanjin

Guilin Sanjin Pharmaceutical Co., Ltd.

Guilin Sanjin Pharmaceutical Co., Ltd. is the core enterprise of Sanjin Group. It mainly engages in the research and development and production of traditional Chinese medicine and natural medicines. It is one of the earliest manufacturers in China to produce modern Chinese medicine preparations. Since 1985, Guilin Sanjin has insisted on reform and innovation, relying on scientific and technological progress and scientific management, and has transformed from an unknown small traditional Chinese medicine workshop into a nationally renowned modern traditional Chinese medicine enterprise. As a well-known high-tech enterprise inside and outside the district, Sanjin has established innovative platforms such as nationally recognized enterprise technology centers, postdoctoral research workstations and Guangxi Institute of Traditional Chinese Medicine Industrialization Engineering. Over the years, we have been committed to promoting and implementing the modernization plan of the traditional Chinese medicine industry and actively cultivating and improving the independent innovation capabilities of enterprises. The company's new special Chinese medicines are all developed by the enterprise technology center. At present, Sanjin has more than 200 registered varieties and 13 pharmaceutical dosage forms, and has 42 special varieties independently developed by Guilin Watermelon Cream, Watermelon Cream Throat Soft Tablets, Sanjin Tablets, Naomaitai Capsules, etc. After years of hard work, Sanjin has formed strong professional and market advantages in throat, oral medication and urinary system medication. Its representative products, Sanjin Watermelon Cream Series and Sanjin Tablets, have been at the forefront of similar Chinese patent medicines in the country for many years. In July 2009, Guilin Sanjin successfully entered the capital market with a new look of high growth and high efficiency, and ushered in a new stage of rapid development of the enterprise. In recent years, in order to actively respond to the call of Guilin Municipal Party Committee and Municipal Government to "develop westward and create a new Guilin", and to resolve the contradiction between the dispersed production bases and warehousing facilities of enterprises and the rapid development of enterprises, Sanjin has launched the "Sanjin". The construction of the modern traditional Chinese medicine industrialization technology transformation project. At present, the first phase of the project has been officially put into production and the overall relocation of the main production lines has been achieved. Facing the future, Sanjin will uphold the corporate mission of "innovation to promote pharmaceutical progress" and the corporate spirit of "dare to be the first", implement the "one body and two wings" development strategy with traditional Chinese medicine as the main body and committed to developing biopharmaceuticals and the big health industry, Quality and reputation are the first life of the enterprise, breakthroughs and innovation, continuously enhances the competitive strength of Sanjin, and is enterprising, with the goal of developing to serve the country and repay investors, and with the goal of building China's advanced pharmaceutical manufacturing group, we will promote the modernization and internationalization of the traditional Chinese medicine industry!

Shenwei Pharmaceutical Group is a large comprehensive enterprise group with the new Chinese medicine industry as its main business, and is listed on the main board of the Hong Kong Stock Exchange. Its main business covers Chinese medicinal materials cultivation, Chinese medicine preparations, Chinese medicine formula granules, Chinese herbal medicines, health products, and biopharmaceuticals. The upstream, midstream and downstream industrial chains have achieved full coverage of the new Chinese medicine industry from the field to the terminal, and are one of the large pharmaceutical enterprise groups with a relatively complete layout in the big health industry. Shenwei Pharmaceutical has formed special products such as modern Chinese medicine injections, modern Chinese medicine soft capsules, modern Chinese medicine granules, and Chinese medicine formula granules for the rapid growth of drugs for middle-aged and elderly people, children's medicine, antiviral drugs, and orthopedic drugs. Looking to the future, Shenwei Pharmaceutical will continue to deepen its development in the new Chinese medicine industry, continuously strengthen its professional academic marketing capabilities and precise brand management capabilities, and be the maker of modern Chinese medicine standards, the leader of modern Chinese medicine technology, and the guarantee of modern Chinese medicine quality. A demonstration of modern Chinese medicine innovation, leading modern Chinese medicine, promoting the health industry, and creating a century-old magical power.

SHINEWAY

Shenwei Pharmaceutical Group Co., Ltd.

Shenwei Pharmaceutical Group is a large comprehensive enterprise group with the new Chinese medicine industry as its main business, and is listed on the main board of the Hong Kong Stock Exchange. Its main business covers Chinese medicinal materials cultivation, Chinese medicine preparations, Chinese medicine formula granules, Chinese herbal medicines, health products, and biopharmaceuticals. The upstream, midstream and downstream industrial chains have achieved full coverage of the new Chinese medicine industry from the field to the terminal, and are one of the large pharmaceutical enterprise groups with a relatively complete layout in the big health industry. Shenwei Pharmaceutical has formed special products such as modern Chinese medicine injections, modern Chinese medicine soft capsules, modern Chinese medicine granules, and Chinese medicine formula granules for the rapid growth of drugs for middle-aged and elderly people, children's medicine, antiviral drugs, and orthopedic drugs. Looking to the future, Shenwei Pharmaceutical will continue to deepen its development in the new Chinese medicine industry, continuously strengthen its professional academic marketing capabilities and precise brand management capabilities, and be the maker of modern Chinese medicine standards, the leader of modern Chinese medicine technology, and the guarantee of modern Chinese medicine quality. A demonstration of modern Chinese medicine innovation, leading modern Chinese medicine, promoting the health industry, and creating a century-old magical power.

Qianjin Pharmaceutical was founded in 1966, carried out joint-stock transformation in 1993, and was listed on the Shanghai Stock Exchange in 2004. The group has 10 holding subsidiaries and has employees of about 7,000. The company's business scope covers fields such as Chinese patent medicines, chemical medicines, Chinese medicine derivatives, wholesale and retail of drugs, and planting and processing of Chinese medicinal materials. In 2006, the company's main product, gynecological daughter tablets, was recognized as a "state secret technology variety"; gynecological daughter tablets (capsules) have been a Category A variety of "National Medical Insurance Catalog" since 1998, and were selected for the 2009 edition, 2012 edition, and 2018 edition. "National Basic Drug Catalog"; Buxue Yimu Pills (granules) have been a variety of "National Medical Insurance Catalog" since 2010 and were selected into the 2018 edition of the "National Basic Drug Catalog".

Qianjin Pharmaceutical Co., Ltd.

Zhuzhou Qianjin Pharmaceutical Co., Ltd.

Qianjin Pharmaceutical was founded in 1966, carried out joint-stock transformation in 1993, and was listed on the Shanghai Stock Exchange in 2004. The group has 10 holding subsidiaries and has employees of about 7,000. The company's business scope covers fields such as Chinese patent medicines, chemical medicines, Chinese medicine derivatives, wholesale and retail of drugs, and planting and processing of Chinese medicinal materials. In 2006, the company's main product, gynecological daughter tablets, was recognized as a "state secret technology variety"; gynecological daughter tablets (capsules) have been a Category A variety of "National Medical Insurance Catalog" since 1998, and were selected for the 2009 edition, 2012 edition, and 2018 edition. "National Basic Drug Catalog"; Buxue Yimu Pills (granules) have been a variety of "National Medical Insurance Catalog" since 2010 and were selected into the 2018 edition of the "National Basic Drug Catalog".

Kun Chinese Medicine started in the 14th year of Hongwu (1381) of Taizu of the Ming Dynasty and officially started construction in the 6th year of Daoguang (1826) of the Qing Dynasty. It has a history of more than 600 years! The company's full name is "Kunming Traditional Chinese Medicine Factory Co., Ltd.", and is a "Chinese time-honored brand" enterprise, a national intangible cultural heritage protection unit, a high-tech enterprise, an Yunnan Enterprise Technology Center, etc. Kun Chinese Medicine is a benchmark enterprise in my country's traditional Chinese medicine industry and represents the development level of advanced traditional Chinese medicine enterprises. Over the past 600 years, the wind and rain have been blowing, spring and autumn fruits have been flourishing. Generations of Kunming Chinese Medicine people have adhered to the spirit of "no reduction and no roughness to cultivate high-quality products, diligent and hardworking, and will be healthy", worked hard, made continuous progress, actively sought, and developed steadily, and achieved remarkable results. Achievements. Kun Chinese Medicine Majinpu production base covers an area of ​​172 mu, designed with the concept of green, environmentally friendly, energy-saving, simplicity and modernity, and introduced intelligent quality testing equipment and traditional Chinese medicine production equipment, with tablets, pills, granules, capsules, 10 dosage forms including powder, syrup, liniment, wine, paste, and mixture, covering the pretreatment, preparation, outsourcing production line and decoction production line of traditional Chinese medicine production. All of them have passed the national GMP certification and realized the traditional Chinese medicine extraction production line and traditional Chinese medicine plastics. Intelligent control of production lines, packaging connections, logistics and other processes. At present, Kun Chinese Medicine is focusing on the vision of "casting high-quality Chinese medicine and serving healthy life", adheres to the mission of "big medicine is virtuous, and sting is embraced", takes customer service as the basis and value sales as the orientation, and actively implements the "big C model". By reaching a "big consensus" with major chains, entering the TOP chain, carrying out "big drainage", "big training", "big detonation" and "big membership", creating core single-product Shenling Jianpiwei Granules, and opening a new spleen-tonifying new The brand potential of the times. Kunming Chinese medicine products have always been well-known in Southeast Asian countries. Many products of Shugan Granules, Qingfei Huatan Pills, Killing Pills, Gastrodia ejaculation pills, and Gastrodia ejaculation and Wind Replenishment Pills have been successfully registered in Vietnam, Singapore, Indonesia and other countries. Kunming Chinese Medicine has been passed down for a century, with a rich history, unique products and excellent quality. "Quality Kunming Chinese Medicine" is a lofty reputation and brand recognition given by consumers. Kun Chinese Medicine has always developed a large number of advantageous varieties with its unique resources, technology, equipment, talents and network advantages, including Shenling Jianpiwei Granules, Shugan Granules, Oropharyngeal Qingwan, Qingfei Huatan Pills, Banlan Qingre Granules, cold anti-inflammatory tablets, cough pills, Nuanwei Shule granules and other medicines.

Kunzhong Pharmaceutical

Kunming Traditional Chinese Medicine Factory Co., Ltd.

Kun Chinese Medicine started in the 14th year of Hongwu (1381) of Taizu of the Ming Dynasty and officially started construction in the 6th year of Daoguang (1826) of the Qing Dynasty. It has a history of more than 600 years! The company's full name is "Kunming Traditional Chinese Medicine Factory Co., Ltd.", and is a "Chinese time-honored brand" enterprise, a national intangible cultural heritage protection unit, a high-tech enterprise, an Yunnan Enterprise Technology Center, etc. Kun Chinese Medicine is a benchmark enterprise in my country's traditional Chinese medicine industry and represents the development level of advanced traditional Chinese medicine enterprises. Over the past 600 years, the wind and rain have been blowing, spring and autumn fruits have been flourishing. Generations of Kunming Chinese Medicine people have adhered to the spirit of "no reduction and no roughness to cultivate high-quality products, diligent and hardworking, and will be healthy", worked hard, made continuous progress, actively sought, and developed steadily, and achieved remarkable results. Achievements. Kun Chinese Medicine Majinpu production base covers an area of ​​172 mu, designed with the concept of green, environmentally friendly, energy-saving, simplicity and modernity, and introduced intelligent quality testing equipment and traditional Chinese medicine production equipment, with tablets, pills, granules, capsules, 10 dosage forms including powder, syrup, liniment, wine, paste, and mixture, covering the pretreatment, preparation, outsourcing production line and decoction production line of traditional Chinese medicine production. All of them have passed the national GMP certification and realized the traditional Chinese medicine extraction production line and traditional Chinese medicine plastics. Intelligent control of production lines, packaging connections, logistics and other processes. At present, Kun Chinese Medicine is focusing on the vision of "casting high-quality Chinese medicine and serving healthy life", adheres to the mission of "big medicine is virtuous, and sting is embraced", takes customer service as the basis and value sales as the orientation, and actively implements the "big C model". By reaching a "big consensus" with major chains, entering the TOP chain, carrying out "big drainage", "big training", "big detonation" and "big membership", creating core single-product Shenling Jianpiwei Granules, and opening a new spleen-tonifying new The brand potential of the times. Kunming Chinese medicine products have always been well-known in Southeast Asian countries. Many products of Shugan Granules, Qingfei Huatan Pills, Killing Pills, Gastrodia ejaculation pills, and Gastrodia ejaculation and Wind Replenishment Pills have been successfully registered in Vietnam, Singapore, Indonesia and other countries. Kunming Chinese Medicine has been passed down for a century, with a rich history, unique products and excellent quality. "Quality Kunming Chinese Medicine" is a lofty reputation and brand recognition given by consumers. Kun Chinese Medicine has always developed a large number of advantageous varieties with its unique resources, technology, equipment, talents and network advantages, including Shenling Jianpiwei Granules, Shugan Granules, Oropharyngeal Qingwan, Qingfei Huatan Pills, Banlan Qingre Granules, cold anti-inflammatory tablets, cough pills, Nuanwei Shule granules and other medicines.

Sichuan Yike Pharmaceutical Co., Ltd. is a high-tech international enterprise with the big health industry as its main line, the biopharmaceutical industry as its core, and the health industry and medical rehabilitation, health care and health management as its wings. There are more than ten subsidiaries, and have established academician and expert workstations, postdoctoral innovation practice bases and enterprise R&D centers. The group has China's advanced Chinese medicine extraction and preparation production capabilities, and has the ability to produce varieties such as medicine and food, health food, and health tablets. The group has formed a modern pharmaceutical industry chain that integrates all aspects of drug research and development, medicinal material planting, Chinese medicine extraction, preparation production and marketing, and has developed and cultivated a group of traditional Chinese and Western medicine products with accurate efficacy and high market reputation, among which the most Representative Ammonia Huangmin Capsules, Gake Compound Aminophen Alkylamine Capsules, Aminophen Namin Granules, Pediatric Aminophen Huangnamin Granules, Amoxicillin Capsules, Multi-enzyme Tablets, Huoxiang Zhengqi Water, Compound Salvia Squid Sinensis Tablets, A series of Chinese and Western medicines such as isatis root granules, Jingxueguanxin granules, Tongmai granules, Tongxuanlifei granules, etc. are highly recognized by consumers. Looking to the future, the Group will vigorously integrate resources and promote the strategy of strengthening talents and managing innovation under the guidance of "sophisticated, meticulous and strict learning, understanding the changes of the situation, specializing in new ideas, and inheriting culture". Medicine is our responsibility, with a scientific, rigorous and responsible attitude, we wholeheartedly create healthy life for the people, and strive to strive for the goals of China's advanced pharmaceutical companies.

Shuzhong

Sichuan Yike Pharmaceutical Co., Ltd.

Sichuan Yike Pharmaceutical Co., Ltd. is a high-tech international enterprise with the big health industry as its main line, the biopharmaceutical industry as its core, and the health industry and medical rehabilitation, health care and health management as its wings. There are more than ten subsidiaries, and have established academician and expert workstations, postdoctoral innovation practice bases and enterprise R&D centers. The group has China's advanced Chinese medicine extraction and preparation production capabilities, and has the ability to produce varieties such as medicine and food, health food, and health tablets. The group has formed a modern pharmaceutical industry chain that integrates all aspects of drug research and development, medicinal material planting, Chinese medicine extraction, preparation production and marketing, and has developed and cultivated a group of traditional Chinese and Western medicine products with accurate efficacy and high market reputation, among which the most Representative Ammonia Huangmin Capsules, Gake Compound Aminophen Alkylamine Capsules, Aminophen Namin Granules, Pediatric Aminophen Huangnamin Granules, Amoxicillin Capsules, Multi-enzyme Tablets, Huoxiang Zhengqi Water, Compound Salvia Squid Sinensis Tablets, A series of Chinese and Western medicines such as isatis root granules, Jingxueguanxin granules, Tongmai granules, Tongxuanlifei granules, etc. are highly recognized by consumers. Looking to the future, the Group will vigorously integrate resources and promote the strategy of strengthening talents and managing innovation under the guidance of "sophisticated, meticulous and strict learning, understanding the changes of the situation, specializing in new ideas, and inheriting culture". Medicine is our responsibility, with a scientific, rigorous and responsible attitude, we wholeheartedly create healthy life for the people, and strive to strive for the goals of China's advanced pharmaceutical companies.

Jinji Pharmaceutical Co., Ltd. integrates medicinal materials planting, research and development, production and sales, focusing on the production of women's medicines. The company has rich product resources and can produce a variety of dosage form drugs such as tablets, granules, capsules, syrups, and pills. The company has rich product resources and has 67 drug approval documents, including 6 exclusive products, forming a series of product combinations of "treatment-raising-protective" with "golden chicken capsules, gold chicken motherwort, and gold chicken antibacterial lotion" as the leader. . The company adheres to the pharmaceutical tenet of "selected raw materials, careful manufacturing, and sincere service" and vigorously creates a listed company for gynecological drug brand in China.

Golden Rooster

Golden Rooster Pharmaceutical Co., Ltd.

Jinji Pharmaceutical Co., Ltd. integrates medicinal materials planting, research and development, production and sales, focusing on the production of women's medicines. The company has rich product resources and can produce a variety of dosage form drugs such as tablets, granules, capsules, syrups, and pills. The company has rich product resources and has 67 drug approval documents, including 6 exclusive products, forming a series of product combinations of "treatment-raising-protective" with "golden chicken capsules, gold chicken motherwort, and gold chicken antibacterial lotion" as the leader. . The company adheres to the pharmaceutical tenet of "selected raw materials, careful manufacturing, and sincere service" and vigorously creates a listed company for gynecological drug brand in China.

Guangzhou Nuojin Pharmaceutical Co., Ltd. is located in Guangzhou Economic and Technological Development Zone. The company was established in July 2003. It is a modern enterprise integrating R&D, production and sales. The company covers an area of ​​40,000 square meters, and its products are mainly oral preparations of Chinese patent medicines. Currently, it has a high-quality preparation production line of various national GMP certified by GMP products, including tablets, hard capsules, granules, pills, glues, traditional Chinese medicine pretreatment and extraction. And by establishing a five-level quality management system of "raw material supply, enterprise decision-making level, quality policy implementation department, production operation front line, drug after-sales service", we vigorously carry out quality management activities for all employees to comprehensively ensure product quality. The company adheres to the business philosophy of "reputation first and quality first". With a solid quality foundation, it has formed a healthy and close cooperative relationship with retail and wholesale companies across the country, including lily solid gold tablets, wet toxin clearing tablets, compound honeysuckle granules, etc. The flagship products have been sold well across the country. At the same time, the new series of Nuojintang Pills, which mainly produces classic prescriptions for all ages, has been launched on the market, which will inject new vitality into the traditional Chinese pill market. The company also continues to carry out various forms of marketing activities and brand promotion activities, participate in social activities, and continuously fulfill the company's social responsibilities. In the future, Guangzhou Nuojin Pharmaceutical Co., Ltd. will continue to improve product quality and broaden the sales network layout, and strive to develop Guangzhou Nuojin Pharmaceutical Co., Ltd. into a modernization with Chinese patent medicine and R&D as its main business, integrating standardized planting of medicinal materials. High-tech pharmaceutical company.

KNOCKIM

Guangzhou Nuojin Pharmaceutical Co., Ltd.

Guangzhou Nuojin Pharmaceutical Co., Ltd. is located in Guangzhou Economic and Technological Development Zone. The company was established in July 2003. It is a modern enterprise integrating R&D, production and sales. The company covers an area of ​​40,000 square meters, and its products are mainly oral preparations of Chinese patent medicines. Currently, it has a high-quality preparation production line of various national GMP certified by GMP products, including tablets, hard capsules, granules, pills, glues, traditional Chinese medicine pretreatment and extraction. And by establishing a five-level quality management system of "raw material supply, enterprise decision-making level, quality policy implementation department, production operation front line, drug after-sales service", we vigorously carry out quality management activities for all employees to comprehensively ensure product quality. The company adheres to the business philosophy of "reputation first and quality first". With a solid quality foundation, it has formed a healthy and close cooperative relationship with retail and wholesale companies across the country, including lily solid gold tablets, wet toxin clearing tablets, compound honeysuckle granules, etc. The flagship products have been sold well across the country. At the same time, the new series of Nuojintang Pills, which mainly produces classic prescriptions for all ages, has been launched on the market, which will inject new vitality into the traditional Chinese pill market. The company also continues to carry out various forms of marketing activities and brand promotion activities, participate in social activities, and continuously fulfill the company's social responsibilities. In the future, Guangzhou Nuojin Pharmaceutical Co., Ltd. will continue to improve product quality and broaden the sales network layout, and strive to develop Guangzhou Nuojin Pharmaceutical Co., Ltd. into a modernization with Chinese patent medicine and R&D as its main business, integrating standardized planting of medicinal materials. High-tech pharmaceutical company.

Founded in 1999, Jimin Kexin is a forefront of the big health industry group in China. It is headquartered in Nanchang, China. It currently has more than 12,000 employees and its business covers medical and health, clean energy, green mineral development and industrial investment. Adhering to the innovation-driven strategic policy, Jimin Trust provides trustworthy guarantees for the health of mankind and the environment through the continuous upgrading of products, technologies and services, and is committed to becoming an internationally advanced modern health industry group. Jimin Kexin has established an integrated pharmaceutical R&D system in Shanghai, Nanjing and New Jersey, USA. It is guided by clinical value and actively participates in international cooperation. By establishing 12 modern pharmaceutical bases in mainland China, it promotes innovative drugs (biomacromolecules, The global development and transformation of cutting-edge technologies and products such as chemical small molecules), innovative Chinese medicines, raw materials and high-end preparations (liposomes, microspheres, inhalers) has been developed and transformed in kidney disease, tumors, cardiovascular and cerebrovascular, respiratory, pain, etc. The field has achieved fruitful results, and its products have been exported to more than 30 countries and regions in Europe and the United States. In order to achieve clean and efficient use of coal and promote global green development, Jimin is trustworthy to build a large coal-to-clean gas production base, which is becoming an ecological engine to help the country achieve the "dual carbon" goal and promote high-quality development of the local economy; Jimin can Xin actively practices the "Two Mountains" theory, invests in the construction of the "Modern Stone Industry Base in Eastern China", and creates a low-carbon and efficient industrial platform with the concept of "making nature more natural", and is committed to promoting the green development of China's mineral resources. Transformation. Jimin is trustworthy and always adheres to the corporate mission of "helping the world and benefiting the people, trusting the world", earnestly fulfills corporate social responsibilities, actively participates in public welfare and charity, and has won the "China Charity Outstanding Contribution Award" of the China Charity Federation and was selected as the Xinhua News Agency National Brand Project . Looking ahead, Jimin is trustworthy and will continue to work tirelessly to improve human health and global green development!

JIMINKEXIN

Jiangxi Jiming Kexin Group Co., Ltd.

Founded in 1999, Jimin Kexin is a forefront of the big health industry group in China. It is headquartered in Nanchang, China. It currently has more than 12,000 employees and its business covers medical and health, clean energy, green mineral development and industrial investment. Adhering to the innovation-driven strategic policy, Jimin Trust provides trustworthy guarantees for the health of mankind and the environment through the continuous upgrading of products, technologies and services, and is committed to becoming an internationally advanced modern health industry group. Jimin Kexin has established an integrated pharmaceutical R&D system in Shanghai, Nanjing and New Jersey, USA. It is guided by clinical value and actively participates in international cooperation. By establishing 12 modern pharmaceutical bases in mainland China, it promotes innovative drugs (biomacromolecules, The global development and transformation of cutting-edge technologies and products such as chemical small molecules), innovative Chinese medicines, raw materials and high-end preparations (liposomes, microspheres, inhalers) has been developed and transformed in kidney disease, tumors, cardiovascular and cerebrovascular, respiratory, pain, etc. The field has achieved fruitful results, and its products have been exported to more than 30 countries and regions in Europe and the United States. In order to achieve clean and efficient use of coal and promote global green development, Jimin is trustworthy to build a large coal-to-clean gas production base, which is becoming an ecological engine to help the country achieve the "dual carbon" goal and promote high-quality development of the local economy; Jimin can Xin actively practices the "Two Mountains" theory, invests in the construction of the "Modern Stone Industry Base in Eastern China", and creates a low-carbon and efficient industrial platform with the concept of "making nature more natural", and is committed to promoting the green development of China's mineral resources. Transformation. Jimin is trustworthy and always adheres to the corporate mission of "helping the world and benefiting the people, trusting the world", earnestly fulfills corporate social responsibilities, actively participates in public welfare and charity, and has won the "China Charity Outstanding Contribution Award" of the China Charity Federation and was selected as the Xinhua News Agency National Brand Project . Looking ahead, Jimin is trustworthy and will continue to work tirelessly to improve human health and global green development!

A renowned herbal extract brand offering Yimu Cao Tincture for menstrual and reproductive health.

Yimu Cao Tincture

Herb Pharm

A renowned herbal extract brand offering Yimu Cao Tincture for menstrual and reproductive health.

A science-based supplement brand offering Yimu Cao Formula for women’s wellness.

Yimu Cao Formula

Pure Encapsulations

A science-based supplement brand offering Yimu Cao Formula for women’s wellness.

A premium supplement brand offering Yimu Cao Powder for hormonal and menstrual regulation.

Yimu Cao Powder

NutraBio Labs

A premium supplement brand offering Yimu Cao Powder for hormonal and menstrual regulation.

A leading brand in nutritional supplements, providing Yimu Cao Capsules for women’s health.

Yimu Cao Capsules

Solaray

A leading brand in nutritional supplements, providing Yimu Cao Capsules for women’s health.

A pioneer in herbal teas, offering Yimu Cao Tea for menstrual and postpartum support.

Yimu Cao Tea

Traditional Medicinals

A pioneer in herbal teas, offering Yimu Cao Tea for menstrual and postpartum support.

A trusted herbal supplement company offering Yimu Cao Complex for women’s reproductive health.

Yimu Cao Complex

Gaia Herbs

A trusted herbal supplement company offering Yimu Cao Complex for women’s reproductive health.

A well-known American brand providing natural health products, including Yimu Cao Extract for menstrual support.

Yimu Cao Extract

NOW Foods

A well-known American brand providing natural health products, including Yimu Cao Extract for menstrual support.

A global herbal supplement brand offering Yimu Cao Granules for women’s wellness and hormonal balance.

Nature’s Way Yimu Cao

Nature’s Way Products, LLC

A global herbal supplement brand offering Yimu Cao Granules for women’s wellness and hormonal balance.

A prominent Chinese pharmaceutical company offering herbal remedies, including Yimu Cao Granules for postpartum recovery.

Herbalist Yimu Cao

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

A prominent Chinese pharmaceutical company offering herbal remedies, including Yimu Cao Granules for postpartum recovery.

A historic Chinese brand known for its high-quality herbal products, including Yi Mu Cao Granules for menstrual health.

Yi Mu Cao

Beijing Tongrentang Co., Ltd.

A historic Chinese brand known for its high-quality herbal products, including Yi Mu Cao Granules for menstrual health.

A trusted herbal extract brand offering Yimu Cao Herbal Extract for menstrual and postpartum care.

Yimu Cao Herbal Extract

Nature’s Answer

A trusted herbal extract brand offering Yimu Cao Herbal Extract for menstrual and postpartum care.

Motherwort Pellets Product

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号